Probiogen AG:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Probiogen AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7541
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥68,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥102,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Probiogen AG (Probiogen) a subsidiary of Minapharm Pharmaceuticals & Chemical Industries is a contract development and manufacturing organization that offers cell line engineering, process development and GMP manufacturing of biopharmaceuticals. The organization’s services comprise therapeutic proteins/antibodies, viral vaccines, biosimilar and biobetter development. It offers contract cell line development, contract process development, contract manufacturing of GMP and non-GMP, protein analytics, and cell-based assays. It develops various technologies for optimized biopharmaceutical manufacturing and analysis. The organization also develops virusproduction system, adcc enhancement, yield enhancement, innovative bioassays and other technologies. Probiogen is headquartered in Berlin, Germany.

Probiogen AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Probiogen AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Probiogen AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Probiogen AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Probiogen AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Probiogen AG, Medical Devices Deals, 2012 to YTD 2018 9
Probiogen AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Probiogen AG, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
ProBioGen Enters into Agreement with Tizona Therapeutics 11
ProBioGen Enters into Agreement with Surface Oncology 12
ProBioGen Enters into Co-Development Agreement with PT Bio Farma 13
ProBioGen Enters into Agreement with Zymeworks 14
Licensing Agreements 15
Nouscom Enters into Licensing Agreement with ProBioGen 15
Chiome Bioscience Enters into Licensing Agreement with ProBioGen 16
ProBioGen Enters into Licensing Agreement with Eucodis Bioscience 17
ProBioGen Enters into Licensing Agreement with Merus 18
ProBioGen Enters into Licensing Agreement with Tizona Therapeutics 19
ProBioGen Enters into Lincencing Agreement with Novartis for GlymaxX ADCC Technology 20
ProBioGen Enters Into Licensing Agreement With Merus For GlymaxX ADCC Technology 21
Probiogen AG – Key Competitors 22
Probiogen AG – Key Employees 23
Probiogen AG – Locations And Subsidiaries 24
Head Office 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Probiogen AG, Pharmaceuticals & Healthcare, Key Facts 2
Probiogen AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Probiogen AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Probiogen AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Probiogen AG, Deals By Therapy Area, 2012 to YTD 2018 8
Probiogen AG, Medical Devices Deals, 2012 to YTD 2018 9
Probiogen AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
ProBioGen Enters into Agreement with Tizona Therapeutics 11
ProBioGen Enters into Agreement with Surface Oncology 12
ProBioGen Enters into Co-Development Agreement with PT Bio Farma 13
ProBioGen Enters into Agreement with Zymeworks 14
Nouscom Enters into Licensing Agreement with ProBioGen 15
Chiome Bioscience Enters into Licensing Agreement with ProBioGen 16
ProBioGen Enters into Licensing Agreement with Eucodis Bioscience 17
ProBioGen Enters into Licensing Agreement with Merus 18
ProBioGen Enters into Licensing Agreement with Tizona Therapeutics 19
ProBioGen Enters into Lincencing Agreement with Novartis for GlymaxX ADCC Technology 20
ProBioGen Enters Into Licensing Agreement With Merus For GlymaxX ADCC Technology 21
Probiogen AG, Key Competitors 22
Probiogen AG, Key Employees 23

List of Figures
Probiogen AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Probiogen AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Probiogen AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Probiogen AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Probiogen AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Probiogen AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Probiogen AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Probiogen AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Probiogen AG, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Probiogen AG:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Vectura Group plc:企業の戦略・SWOT・財務情報
    Vectura Group plc - Strategy, SWOT and Corporate Finance Report Summary Vectura Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • IOI Corp Berhad (IOICORP):企業の財務・戦略的SWOT分析
    IOI Corp Berhad (IOICORP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Viridian Energy Supply Ltd:企業の戦略的SWOT分析
    Viridian Energy Supply Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Australian Agricultural Company Limited:企業の戦略・SWOT・財務情報
    Australian Agricultural Company Limited - Strategy, SWOT and Corporate Finance Report Summary Australian Agricultural Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Statoil ASA:企業のM&A・事業提携・投資動向
    Statoil ASA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Statoil ASA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • PT ANTAM (Persero) Tbk:企業の戦略・SWOT・財務情報
    PT ANTAM (Persero) Tbk - Strategy, SWOT and Corporate Finance Report Summary PT ANTAM (Persero) Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Taiwan High Speed Rail Corporation
    Taiwan High Speed Rail Corporation - Strategy, SWOT and Corporate Finance Report Summary Taiwan High Speed Rail Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Global Foundries Inc:企業のM&A・事業提携・投資動向
    Global Foundries Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Global Foundries Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Proteus Digital Health Inc:医療機器:M&Aディール及び事業提携情報
    Summary Proteus Digital Health Inc (Proteus) is a digital medicine company that develops and sells medicines for chronic diseases through in-house research and through partnership with the pharmaceutical, medical device and biotechnology companies. Its flagship product, Proteus Discover digital medi …
  • The Kansai Electric Power Co Inc (9503):電力:M&Aディール及び事業提携情報
    Summary The Kansai Electric Power Co Inc (KEPCo) is an integrated power utility. It produces and supplies electricity and thermal energy; and procures and sells natural gas. The company generates electricity using natural gas, nuclear, coal, oil, wind, hydro, and solar sources. Through long, medium, …
  • Rush Enterprises, Inc. (RUSHA):企業の財務・戦略的SWOT分析
    Rush Enterprises, Inc. (RUSHA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Immunomedics Inc (IMMU):企業の財務・戦略的SWOT分析
    Immunomedics Inc (IMMU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Tzamal Medical Group Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Tzamal Medical Group Ltd (Tzamal Medical) is a medical device company that manufactures and markets medical equipment, implants, disposables, surgical instruments and veterinary drugs. The company’s products include disposable products, patient monitor equipment and patient self testing equi …
  • SMA Solar Technology AG (S92)-エネルギー分野:企業M&A・提携分析
    Summary SMA Solar Technology AG (SMA) is a renewable energy company that develops, produces, and distributes photovoltaic (PV) inverters, transformers, choke coils, and monitoring and energy management systems for PV systems. It also offers operation and maintenance services for photovoltaic power p …
  • Knoll, Inc.:戦略・SWOT・企業財務分析
    Knoll, Inc. - Strategy, SWOT and Corporate Finance Report Summary Knoll, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • J.K. Cement Ltd (JKCEMENT):企業の財務・戦略的SWOT分析
    J.K. Cement Ltd (JKCEMENT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Pets at Home Group Plc (PETS):企業の財務・戦略的SWOT分析
    Pets at Home Group Plc (PETS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Anthera Pharmaceuticals Inc:企業のM&A・事業提携・投資動向
    Anthera Pharmaceuticals Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Anthera Pharmaceuticals Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Boart Longyear Ltd:企業の戦略・SWOT・財務情報
    Boart Longyear Ltd - Strategy, SWOT and Corporate Finance Report Summary Boart Longyear Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Rowan Companies Plc (RDC):石油・ガス:M&Aディール及び事業提携情報
    Summary Rowan Companies Plc (Rowan) is a provider of offshore contract drilling services to the oil and gas industry. It provides drilling services in the in the ultra-deepwater and shallow water jack-up market. Rowan operates self-elevating mobile offshore drilling units and ultra-deepwater drillsh …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆